Palisade Capital Management’s BioLife Solutions BLFS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.5M	Sell	758,659 -52,351	-6%	-$1.16M	0.48%	77
2025 Q4	$19.6M	Sell	811,010 -97,430	-11%	-$2.55M	0.58%	62
2025 Q3	$23.2M	Sell	908,440 -11,019	-1%	-$261K	0.63%	58
2025 Q2	$19.8M	Sell	919,459 -27,626	-3%	-$623K	0.56%	70
2025 Q1	$21.6M	Buy	947,085 +113,937	+14%	+$3M	0.62%	61
2024 Q4	$21.6M	Buy	833,148 +12,004	+1%	+$299K	0.58%	68
2024 Q3	$20.6M	Sell	821,144 -411,568	-33%	-$9.72M	0.55%	73
2024 Q2	$26.4M	Sell	1,232,712 -19,790	-2%	-$384K	0.72%	49
2024 Q1	$23.2M	Buy	1,252,502 +39,168	+3%	+$685K	0.61%	61
2023 Q4	$19.7M	Sell	1,213,334 -150,304	-11%	-$1.92M	0.52%	69
2023 Q3	$18.8M	Buy	1,363,638 +229,286	+20%	+$3.61M	0.53%	70
2023 Q2	$25.1M	Buy	1,134,352 +54,538	+5%	+$1.15M	0.67%	52
2023 Q1	$23.5M	Buy	1,079,814 +50,191	+5%	+$1.13M	0.63%	50
2022 Q4	$18.7M	Buy	1,029,623 +107,080	+12%	+$2.21M	0.5%	68
2022 Q3	$21M	Buy	922,543 +2,359	+0.3%	+$50.5K	0.59%	55
2022 Q2	$12.7M	Buy	920,184 +368,415	+67%	+$5.41M	0.34%	90
2022 Q1	$12.5M	Sell	551,769 -38,219	-6%	-$1.01M	0.29%	110
2021 Q4	$22M	Buy	589,988 +5,687	+1%	+$244K	0.45%	77
2021 Q3	$24.7M	Buy	584,301 +108,617	+23%	+$5.23M	0.54%	64
2021 Q2	$21.2M	Buy	475,684 +96,573	+25%	+$3.4M	0.48%	73
2021 Q1	$13.6M	Buy	+379,111	New	+$15M	0.32%	110